Capricor Therapeutics Files 8-K Report
Ticker: CAPR · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1133869
| Field | Detail |
|---|---|
| Company | Capricor Therapeutics, Inc. (CAPR) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
Related Tickers: CAPR
TL;DR
CAPR filed an 8-K for routine disclosures. No major news.
AI Summary
On July 11, 2025, Capricor Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits, indicating routine corporate reporting rather than a specific material event. The company, formerly known as Nile Therapeutics, Inc., is based in San Diego, California.
Why It Matters
This filing serves as a standard disclosure for Capricor Therapeutics, Inc., providing updates on financial statements and exhibits as required by the SEC.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report for disclosures and exhibits, not indicating any specific new risks or material events.
Key Players & Entities
- CAPRICOR THERAPEUTICS, INC. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- Nile Therapeutics, Inc. (company) — Former company name
- San Diego, California (location) — Principal executive office address
FAQ
What is the primary purpose of this 8-K filing for Capricor Therapeutics, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date was this 8-K report filed or effective?
The report was filed as of July 11, 2025.
What is the principal executive office address for Capricor Therapeutics, Inc.?
The address of the principal executive office is 10865 Road to the Cure, Suite 150, San Diego, California.
Has Capricor Therapeutics, Inc. operated under any former names?
Yes, Capricor Therapeutics, Inc. was formerly known as Nile Therapeutics, Inc. and SMI PRODUCTS INC.
What is the Standard Industrial Classification (SIC) code for Capricor Therapeutics, Inc.?
The Standard Industrial Classification code for Capricor Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding CAPRICOR THERAPEUTICS, INC. (CAPR).